A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors
A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors
Recruiting · NCT07229612 · Registry updated 2026-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors | Malignant Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-08-12 | NCT07229612 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 74 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Guangzhou Medical University | Guangzhou | China | 1 |